Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).

Date publication

mai 2025

Journal

JMIR cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSI Cédric

Tous les auteurs :
Le Dû K, Chauchet A, Sadot-Lebouvier S, Fitoussi O, Fontanet B, Saint-Lezer A, Maloisel F, Rossi C, Carras S, Parcelier A, Balavoine M, Septans AL

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40327037

Résumé

Relapse is a major event in patients with lymphoma. Therefore, early detection may have an impact on quality of life and overall survival. Patient-reported outcome measures have demonstrated clinical benefits for patients with lung cancer; however, evidence is lacking in patients with lymphoma. We evaluated the effect of a web-mediated follow-up application for patients with lymphoma at high risk of relapse.

Mots clés

Hodgkin lymphoma, T-cell lymphoma, detection, lymphoma, patient-reported outcome measures, progression, quality of life, randomized trial, relapse, risk of relapse, survival, web-based

Référence

JMIR Cancer. 2025 05 6;11:e65960